Remote Patient Monitoring System Global Market Report 2025

The remote patient monitoring system market size has grown exponentially in recent years. It will grow from $4.29 billion in 2024 to $5.19 billion in 2025 at a compound annual growth rate (CAGR) of 20.9%. Growth during the historical period was driven by the increasing burden of chronic illnesses, rising use of telehealth and telemedicine, heightened need for home-based care, escalating healthcare expenses prompting cost-efficient solutions, and a growing elderly population worldwide.

The remote patient monitoring system market size is expected to see exponential growth in the next few years. It will grow to $11 billion in 2029 at a compound annual growth rate (CAGR) of 20.6%. Factors contributing to this projected growth include a stronger focus on personalized and value-driven care delivery, wider implementation of 5G networks supporting seamless real-time communication, enhanced investment in healthcare IT systems, rising partnerships between tech firms, and the broadening scope of hospital-at-home initiatives. Key market trends anticipated in the forecast period include the increasing use of AI and machine learning, deeper integration with telehealth solutions, migration toward cloud-based data storage, innovations in power and battery technologies, and a growing shift towards at-home healthcare services.

The rising incidence of cardiac conditions is expected to drive the growth of the remote patient monitoring system market. Cardiac conditions refer to diseases or disorders that affect the heart's structure, function, or rhythm, including coronary artery disease, heart failure, and arrhythmias. The growing prevalence of these conditions is largely attributed to unhealthy lifestyle habits. Remote patient monitoring systems support the management of cardiac conditions by continuously tracking vital signs such as heart rate, blood pressure, and electrocardiogram (ECG) outside traditional clinical settings. This continuous monitoring enables early detection, timely intervention, and better treatment adherence, ultimately reducing hospitalizations and slowing disease progression. For example, a report by the American Heart Association, a US-based nonprofit organization, indicated that total cardiovascular-related deaths rose slightly to 931,578 in the current year, representing an increase of fewer than 3,000 deaths from 928,741 the previous year. As such, the increasing incidence of cardiac conditions is a key driver of the remote patient monitoring system market.

Companies in the remote patient monitoring system market are prioritizing technological advancements, including wearable sensors, to improve real-time health data collection, enhance patient engagement, and support proactive clinical decision-making. These wearable sensors are compact electronic devices worn on the body, designed to measure and record healthcare-related metrics like heart rate, body temperature, blood oxygen levels, and physical movement, allowing continuous real-time monitoring of physiological conditions. For instance, in October 2024, BioIntelliSense, Inc., a US-based company specializing in continuous health monitoring and clinical intelligence, received FDA clearance for its rechargeable BioButton Multi-Patient wearable and BioDashboard system. This reusable device enables continuous vital sign monitoring in various hospital settings and supports hospital-at-home care. The BioDashboard employs AI-driven exception management, allowing a single clinician to oversee hundreds of patients through real-time trend analysis, leading to improved clinical outcomes on a large scale.

In August 2022, Medtronic plc, a medical technology company headquartered in Ireland, partnered with BioIntelliSense, Inc. The collaboration is intended to enhance patient safety and care efficiency by integrating continuous, connected remote monitoring from the hospital to the home using BioIntelliSense’s BioButton wearable device. BioIntelliSense is a US-based medical technology company that offers remote patient monitoring systems.

Major players in the remote patient monitoring system market are Johnson & Johnson, Abbott Laboratories, Honeywell International Inc., Medtronic plc, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Boston Scientific Corporation, Resideo Life Care Solutions, Omron Corporation, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Drägerwerk AG & Co. KGaA, Teladoc Health Inc., Masimo Corporation, Biotronik SE & Co. KG, Nihon Kohden Corporation, OSI Systems Inc., iRhythm Technologies Inc., Health Recovery Solutions Inc., LifeWatch AG, VitalConnect Inc., Vivify Health Inc., Welch Allyn Inc., Vitls Inc., and Bio-Beat Technologies Ltd.

North America was the largest region in the remote patient monitoring system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in remote patient monitoring system report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the remote patient monitoring system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A remote patient monitoring (RPM) system is a healthcare innovation that enables medical professionals to track patients' health data from locations outside traditional medical facilities, typically at home. It employs connected devices such as blood pressure monitors, glucose meters, and wearable sensors to gather and transmit real-time health information. The core objective of an RPM system is to enhance patient outcomes by allowing for continuous health tracking, early detection of potential issues, and prompt medical response.

Remote patient monitoring systems are categorized mainly into two product types: vital sign monitors and specialized monitors. Vital sign monitors are medical tools designed to periodically or continuously assess key physiological indicators like heart rate, blood pressure, respiratory rate, body temperature, and blood oxygen saturation to evaluate a patient's health condition. These systems incorporate various components including hardware devices, software solutions, and support services. They are widely used across multiple medical applications such as cancer, cardiovascular diseases, diabetes, sleep-related disorders, weight and fitness tracking, bronchitis, infectious diseases, and other health concerns. The major end-users include hospitals, home-based care settings, ambulatory care centers, and other healthcare institutions.

The remote patient monitoring system market research report is one of a series of new reports that provides remote patient monitoring system market statistics, including the remote patient monitoring system industry global market size, regional shares, competitors with the remote patient monitoring system market share, detailed remote patient monitoring system market segments, market trends, and opportunities, and any further data you may need to thrive in the remote patient monitoring system industry. This remote patient monitoring system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The remote patient monitoring system market consists of revenues earned by entities by providing services such as device installation and setup, technical support and maintenance, clinical workflow integration, and alert and notification services. The market value includes the value of related goods sold by the service provider or included within the service offering. The remote patient monitoring system market also includes sales of wearable devices, biosensors, data analytics tools, and software platforms. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.